Unlock instant, AI-driven research and patent intelligence for your innovation.

Montelukast Sodium Chewable Tablets and Preparation Method of Powder Direct Compression Tablets

A technology of montelukast sodium and chewable tablets, which is applied in the field of chemical pharmacy, can solve problems such as high process requirements, unstable product preparation process, and complexity, so as to save the granulation process, simplify the production and preparation process, and improve production efficiency Effect

Active Publication Date: 2016-03-16
XINJIANG TEFENG PHARMA
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The present invention provides a kind of montelukast sodium chewable tablet and its powder direct compression preparation method, which overcomes the above-mentioned deficiencies in the prior art, and it can effectively solve the problem of The current preparation process of the asthma treatment drug Montelukastina preparations easily leads to product instability, complicated preparation process, and high process requirements.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Montelukast Sodium Chewable Tablets and Preparation Method of Powder Direct Compression Tablets

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Embodiment 1, the raw material of this montelukast sodium chewable tablet comprises 1.5 parts to 2 parts of montelukast sodium, 30 parts to 35 parts of mannitol, 15 parts to 20 parts of xylitol, microcrystalline 30 to 40 parts of cellulose, 6 to 12 parts of sodium carboxymethyl starch, 0.5 to 1.5 parts of magnesium stearate, 1.5 to 3 parts of micronized silica gel and 0.5 to 2 parts of red iron oxide. Described microcrystalline cellulose, mannitol, xylitol are diluents, are mainly used in increasing the weight and volume of tablet; Simultaneously, xylitol also has flavoring agent effect; Described sodium carboxymethyl starch is disintegrating The agent is mainly used to accelerate the rapid disintegration of the tablet into fine particles in the gastrointestinal fluid to accelerate the absorption; the micropowder silica gel and magnesium stearate are lubricants, and since the magnesium stearate has a certain influence on the stability of the drug, Therefore these two ar...

Embodiment 2

[0018] Embodiment 2, the raw material of this montelukast sodium chewable tablet comprises 1.5 parts or 2 parts of montelukast sodium, 30 parts or 35 parts of mannitol, 15 parts or 20 parts of xylitol, microcrystalline 30 or 40 parts of cellulose, 6 or 12 parts of sodium carboxymethyl starch, 0.5 or 1.5 parts of magnesium stearate, 1.5 or 3 parts of micronized silica gel and 0.5 or 2 parts of red iron oxide.

Embodiment 3

[0019] Embodiment 3, as the preference of the above-mentioned embodiment, the montelukast sodium chewable tablet is obtained by the following powder direct compression tablet preparation method: in the first step, the required amount of mannitol, xylitol, microcrystalline cellulose and sodium carboxymethyl starch through a 100-mesh sieve and mix uniformly to obtain the first mixture; in the second step, pass the required amount of micronized silica gel and magnesium stearate through a 100-mesh sieve and mix uniformly to obtain the second mixture; the third step , mix the required amount of montelukast sodium with red ferric oxide to obtain the third mixture; the fourth step, after mixing the first mixture and the second mixture, continue to add the third mixture to it and mix evenly Obtain the powdered medicine; the fifth step, pass the powdered medicine through an 80-mesh sieve, and then press into tablets to obtain montelukast sodium chewable tablets. During the tablet press...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
friabilityaaaaaaaaaa
Login to View More

Abstract

The invention relates to the technical field of chemical pharmacy, and relates to a preparation method of montelukast sodium chewable tablet and powder direct compression tablet thereof. The raw materials of montelukast sodium chewable tablets include montelukast turner in parts by weight 1.5 parts to 2 parts, mannitol 30 parts to 35 parts, xylitol 15 parts to 20 parts, microcrystalline cellulose 30 parts to 40 parts, sodium carboxymethyl starch 6 parts to 12 parts, magnesium stearate 0.5 parts to 1.5 parts, micronized silica gel 1.5 parts to 3 parts and red iron oxide 0.5 parts to 2 share. The present invention adopts powder direct tableting method to carry out tabletting, not only avoids Montelukastina being sensitive to humidity and causes preparation instability, makes the stability of the present invention better, and saves the granulation process, simplifies the production preparation process and is convenient to implement, Greatly shorten the production cycle and improve production efficiency.

Description

technical field [0001] The invention relates to the technical field of chemical pharmacy, and relates to a preparation method of montelukast sodium chewable tablet and powder direct compression tablet thereof. Background technique [0002] Asthma is a chronic inflammatory disease characterized by tracheal hyperresponsiveness and reversible airway obstruction. It is recognized by the world medical community as one of the four chronic diseases and is listed as the top ten causes of death. In recent years, the morbidity and mortality of asthma have shown an upward trend worldwide, especially in my country, where the current prevalence of asthma is about 1%, and children can reach 3%. It can be seen that my country has a huge number of asthma patients group. Leukotrienes are one of the important mediators of bronchial asthma, and play an important role in its occurrence and development. Therefore, leukotriene receptor antagonists have become a new approach for the treatment of a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K31/47A61P11/06
Inventor 高晓黎明婷程志斌王卫东
Owner XINJIANG TEFENG PHARMA